Anti-tumor activities of decursinol angelate and decursin from Angelica gigas

Arch Pharm Res. 2003 Sep;26(9):727-30. doi: 10.1007/BF02976682.

Abstract

The in vivo anti-tumor activities of decursinol angelate (1) and decursin (2) isolated from the roots of Angelica gigas were investigated. These two compounds, when administered consecutively for 9 days at 50 and 100 mg/kg i.p. in mice, caused a significant increase in the life span and a significant decrease in the tumor weight and volume of mice inoculated with Sarcoma-180 tumor cells. These results suggest that decursinol angelate (1) and decursin (2) from A. gigas have anti-tumor activities.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angelica / chemistry*
  • Animals
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification*
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Benzopyrans / chemistry
  • Benzopyrans / isolation & purification*
  • Benzopyrans / pharmacology*
  • Butyrates / chemistry
  • Butyrates / isolation & purification*
  • Butyrates / pharmacology*
  • Cell Line, Tumor / transplantation
  • Fluorouracil / administration & dosage
  • Fluorouracil / pharmacokinetics
  • Fluorouracil / therapeutic use
  • Injections, Intraperitoneal
  • Korea
  • Male
  • Medicine, East Asian Traditional
  • Mice
  • Mice, Inbred ICR
  • Neoplasm Transplantation / pathology
  • Neoplasms / drug therapy
  • Neoplasms / etiology
  • Neoplasms / pathology
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Roots / chemistry
  • Sarcoma 180 / drug therapy
  • Sarcoma 180 / pathology
  • Survival Rate

Substances

  • Antineoplastic Agents, Phytogenic
  • Benzopyrans
  • Butyrates
  • Plant Extracts
  • decursin
  • Fluorouracil